SK287522B6 - Použitie inhibítorov produkcie a/alebo účinku IL-18 - Google Patents

Použitie inhibítorov produkcie a/alebo účinku IL-18 Download PDF

Info

Publication number
SK287522B6
SK287522B6 SK88-2002A SK882002A SK287522B6 SK 287522 B6 SK287522 B6 SK 287522B6 SK 882002 A SK882002 A SK 882002A SK 287522 B6 SK287522 B6 SK 287522B6
Authority
SK
Slovakia
Prior art keywords
cells
hse
production
tnf
inhibitor
Prior art date
Application number
SK88-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK882002A3 (en
Inventor
Charles Dinarello
Original Assignee
Ares Trading S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading S. A. filed Critical Ares Trading S. A.
Publication of SK882002A3 publication Critical patent/SK882002A3/sk
Publication of SK287522B6 publication Critical patent/SK287522B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK88-2002A 1999-07-22 2000-07-17 Použitie inhibítorov produkcie a/alebo účinku IL-18 SK287522B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors
PCT/IL2000/000419 WO2001007480A2 (en) 1999-07-22 2000-07-17 Use of interleukin-18 inhibitors to inhibit tumor metastasis

Publications (2)

Publication Number Publication Date
SK882002A3 SK882002A3 (en) 2002-07-02
SK287522B6 true SK287522B6 (sk) 2011-01-04

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
SK88-2002A SK287522B6 (sk) 1999-07-22 2000-07-17 Použitie inhibítorov produkcie a/alebo účinku IL-18

Country Status (31)

Country Link
US (1) US7741276B2 (bg)
EP (1) EP1206274B1 (bg)
JP (1) JP4827352B2 (bg)
KR (1) KR100682219B1 (bg)
CN (1) CN1173736C (bg)
AR (1) AR024907A1 (bg)
AT (1) ATE363288T1 (bg)
AU (1) AU782478B2 (bg)
BG (1) BG65800B1 (bg)
BR (1) BR0012675A (bg)
CA (1) CA2380216C (bg)
CY (1) CY1107932T1 (bg)
CZ (1) CZ302114B6 (bg)
DE (2) DE60035049T2 (bg)
DK (1) DK1206274T3 (bg)
EA (1) EA005419B1 (bg)
EE (1) EE04838B1 (bg)
ES (1) ES2186596T3 (bg)
HK (1) HK1048248B (bg)
HU (1) HU228780B1 (bg)
IL (2) IL131047A0 (bg)
MX (1) MXPA02000838A (bg)
NO (1) NO329827B1 (bg)
NZ (1) NZ516535A (bg)
PL (1) PL202477B1 (bg)
PT (1) PT1206274E (bg)
SK (1) SK287522B6 (bg)
TR (1) TR200200169T2 (bg)
UA (1) UA73745C2 (bg)
WO (1) WO2001007480A2 (bg)
ZA (1) ZA200200390B (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101111103B1 (ko) 2000-02-10 2012-02-13 아보트 러보러터리즈 사람 인터류킨-18에 결합하는 항체 및 이를 제조하고 사용하는 방법
EP1331943A4 (en) 2000-10-11 2005-01-26 Viron Therapeutics Inc NUCLEIC ACID MOLECULES AND POLYPEPTIDES FOR IMMUNOMODULATION
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
ES2416510T3 (es) * 2002-10-08 2013-08-01 Ares Trading S.A. Uso de una citocina capaz de unirse a IL 18BP y de inhibir la actividad de una segunda citocina
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
US7691611B2 (en) 2005-06-03 2010-04-06 Ares Trading S.A. Production of recombinant IL-18 binding protein
JP5091127B2 (ja) 2005-06-10 2012-12-05 アレス トレーディング ソシエテ アノニム Ｉｌ−１８結合タンパク質の精製のための方法
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
AU2023236289A1 (en) 2022-03-15 2024-08-15 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005333A1 (en) * 1992-09-02 1994-03-17 Isis Pharmaceuticals, Inc. Oligonucleotide modulation of cell adhesion
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
SK122199A3 (en) * 1997-03-18 2000-12-11 Basf Ag Methods and compositions for modulating responsiveness to corticosteroids
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
TR200200169T2 (tr) 2002-06-21
DE60035049T2 (de) 2007-09-27
IL131047A0 (en) 2001-01-28
IL147675A (en) 2009-05-04
US7741276B2 (en) 2010-06-22
KR20020027493A (ko) 2002-04-13
MXPA02000838A (es) 2002-07-30
WO2001007480A3 (en) 2001-05-10
DE60035049D1 (de) 2007-07-12
CY1107932T1 (el) 2013-09-04
JP4827352B2 (ja) 2011-11-30
EA005419B1 (ru) 2005-02-24
UA73745C2 (en) 2005-09-15
PL202477B1 (pl) 2009-06-30
CA2380216A1 (en) 2001-02-01
BRPI0012675B8 (bg) 2021-05-25
EP1206274A2 (en) 2002-05-22
HU228780B1 (en) 2013-05-28
PL353732A1 (en) 2003-12-01
HUP0202107A3 (en) 2005-01-28
WO2001007480A2 (en) 2001-02-01
JP2003505472A (ja) 2003-02-12
EA200200189A1 (ru) 2002-12-26
BRPI0012675B1 (pt) 2001-02-01
NO329827B1 (no) 2011-01-03
CA2380216C (en) 2012-01-31
BG65800B1 (bg) 2009-12-31
BG106311A (bg) 2002-08-30
ZA200200390B (en) 2003-04-30
DE1206274T1 (de) 2002-11-14
NZ516535A (en) 2004-04-30
AU782478B2 (en) 2005-08-04
AR024907A1 (es) 2002-10-30
NO20020153L (no) 2002-03-11
CN1173736C (zh) 2004-11-03
BR0012675A (pt) 2002-04-09
KR100682219B1 (ko) 2007-02-12
CZ2002195A3 (cs) 2002-06-12
AU5843200A (en) 2001-02-13
ES2186596T3 (es) 2007-11-16
EP1206274B1 (en) 2007-05-30
CN1364086A (zh) 2002-08-14
SK882002A3 (en) 2002-07-02
EE04838B1 (et) 2007-06-15
ATE363288T1 (de) 2007-06-15
HUP0202107A2 (en) 2002-10-28
NO20020153D0 (no) 2002-01-11
PT1206274E (pt) 2007-07-06
HK1048248B (zh) 2005-04-22
DK1206274T3 (da) 2007-08-13
EE200200032A (et) 2003-02-17
CZ302114B6 (cs) 2010-10-20
ES2186596T1 (es) 2003-05-16
US20080003216A1 (en) 2008-01-03
HK1048248A1 (en) 2003-03-28

Similar Documents

Publication Publication Date Title
Noack et al. Selected cytokine pathways in rheumatoid arthritis
Dinarello Interleukin-18
Dinarello IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family
US7741276B2 (en) Use of interleukin-18 inhibitors to inhibit tumor metastasis
US8178308B2 (en) Use of IL-27 agonists to increase interferon-gamma production
CN1322897C (zh) Il－18抑制剂的应用
Jayaraman et al. Enhancement of in vivo cell-mediated immune responses by three distinct cytokines.
JP2005532256A (ja) 慢性関節リウマチを治療するためのｌｉｒ機能の調節
CA2306790A1 (en) Application of tnf antagonists as medicaments for treating septic diseases
Agematsu et al. Ki-1 positive large cell anaplastic lymphoma: multiple bone lytic lesions and interleukin-6
Debets Inflammatory cytokines and their receptors in psoriatic skin: emphasis on the epidermal interleukin 1 system
Verbsky Non-hematopoietic expression of Jak3 is required for efficient allergic airway inflammation

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20200717